Quality of life in patients with leber hereditary optic neuropathy

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3112-3115

  Kirkman, Matthew Anthony ^a   Korsten, Alex ^b   Leonhardt, Miriam ^c   Dimitriadis, Konstantin ^c   de Coo, Ireneaus F ^b   Klopstock, Thomas ^c   Griffiths, Philip G ^a,d   Hudson, Gavin ^a   Chinnery, Patrick F ^a,e   Yu Wai Man, Patrick ^a,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; MITOCHONDRIAL DNA; THYMINE;

ADL DISABILITY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COOKING; DISEASE DURATION; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; INTERVIEW; LEBER HEREDITARY OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PEDIGREE ANALYSIS; PLAY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; READING; SEX RATIO; TELEVISION; VISUAL DISCRIMINATION; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; WRITING; BLINDNESS; DAILY LIFE ACTIVITY; GENETICS; HETEROZYGOTE; MIDDLE AGED; PEDIGREE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; SICKNESS IMPACT PROFILE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BLINDNESS; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; OPTIC ATROPHY, HEREDITARY, LEBER; PEDIGREE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; YOUNG ADULT;

EID: 67649989579     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3166     Document Type: Article

References (26)

1. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet. 1995;57(1):77-86.
2. Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004; 18(11):1144-1160.
3. Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59(2):481-485.
4. Man PYW, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet. 2003;72(2): 333-339.
5. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet. 2008;83(2):254-260.
6. Spruijt L, Kolbach DN, de Coo R, et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol. 2006;141(4):676-682.
7. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet. 2002;39(3):162-169.
8. Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. BMJ. 2001;322(7297):1297-1300.
9. Steinberg EP, Tielsen JM, Schien OD, et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112(5):630-638.
10. Norregaard JC, Bernth-Petersen P, Alonso J, Andersen TF, Anderson GF. Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: report of the International Cataract Surgery Outcomes Study. J Cataract Refract Surg. 2003;29(11):2135-2142.
11. Sabri K, Knapp CM, Thompson JR, Gottlob I. The VF-14 and psychological impact of amblyopia and strabismus. Invest Ophthalmol Vis Sci. 2006;47(10):4386-4392.
12. Pilling RF, Thompson JR, Gottlob I. Social and visual function in nystagmus. Br J Ophthalmol. 2005;89(10):1278-1281.
13. Mackenzie PJ, Chang TS, Scott IU, et al. Assessment of visionrelated function in patients with age-related macular degeneration. Ophthalmology. 2002;109(4):720-729.
14. Linder M, Chang TS, Scott IU, et al. Validity of the visual function index (VF-14) in patients with retinal disease. Arch Ophthalmol. 1999;117(12):1611-1616.
15. Rose K, Harper R, Tromans C, et al. Quality of life in myopia. Br J Ophthalmol. 2000;84(9):1031-1034.
16. Boisjoly H, Grosset J, Fontaine N, et al. The VF-14 index of functional visual improvement in candidates for corneal graft. Am J Ophthalmol. 2002;134(2):166-171.
17. Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ. Quality of life of low vision patients and the impact of low vision services. Am J Ophthalmol. 1999;128(1):54-62.
18. Kerrison JB, Newman NJ. Clinical spectrum of Leber's hereditary optic neuropathy. Clin Neurosci. 1997;4(5):295-301.
19. Nakamura M, Yamamoto M. Variable pattern of visual recovery of Leber's hereditary optic neuropathy. Br J Ophthalmol. 2000;84(5): 534-535.
20. Yu Wai Man CY, Smith T, Chinnery PF, Turnbull DM, Griffiths PG. Assessment of visual function in chronic progressive external ophthalmoplegia. Eye. 2006;20(5):564-568.
21. Van Senus AHC. Leber's disease in the Netherlands. Doc Ophthalmol. 1963;17:1-163.
22. Steinberg EP, Tielsch JM, Schein OD, et al. National study of cataract surgery outcomes: variation in 4-month postoperative outcomes as reflected in multiple outcome measures (comment). Ophthalmology. 1994;101(6):1131-1140; discussion 1140-1141.
23. Alonso J, Espallargues M, Andersen TF, et al. International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology. 1997;104(5):799-807.
24. Cassard SD, Patrick DL, Damiano AM, et al. Reproducibility and responsiveness of the VF-14. An index of functional impairment in patients with cataracts. Arch Ophthalmol. 1995;113(12):1508-1513.
25. Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM. Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology. 2006;66(12):1932-1934.
26. Schaefer AM, McFarland R, Blakely EL, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 2008;63(1):35-39.